Ahead of Ventas (VTR) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Werte in diesem Artikel
Wall Street analysts expect Ventas (VTR) to post quarterly earnings of $0.85 per share in its upcoming report, which indicates a year-over-year increase of 6.3%. Revenues are expected to be $1.37 billion, up 14.3% from the year-ago quarter.The current level reflects an upward revision of 0.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.With that in mind, let's delve into the average projections of some Ventas metrics that are commonly tracked and projected by analysts on Wall Street.The collective assessment of analysts points to an estimated 'Revenues- Rental income- Outpatient medical & research portfolio' of $222.56 million. The estimate points to a change of +1.7% from the year-ago quarter.According to the collective judgment of analysts, 'Revenues- Interest and other income' should come in at $2.98 million. The estimate indicates a change of -38.2% from the prior-year quarter.Analysts predict that the 'Revenues- Resident fees and services' will reach $977.05 million. The estimate indicates a change of +19.5% from the prior-year quarter.Based on the collective assessment of analysts, 'Revenues- Rental income- Triple-net leased' should arrive at $153.51 million. The estimate points to a change of -0.3% from the year-ago quarter.The consensus among analysts is that 'Revenues- Third party capital management revenues' will reach $4.38 million. The estimate points to a change of +1.1% from the year-ago quarter.Analysts' assessment points toward 'Depreciation and amortization' reaching $319.33 million. View all Key Company Metrics for Ventas here>>> Ventas shares have witnessed a change of +3.3% in the past month, in contrast to the Zacks S&P 500 composite's +3.6% move. With a Zacks Rank #3 (Hold), VTR is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Higher. Faster. Sooner. Buy These Stocks NowA small number of stocks are primed for a breakout, and you have a chance to get in before they take off.At any given time, there are only 220 Zacks Rank #1 Strong Buys. On average, this list more than doubles the S&P 500. We’ve combed through the latest Strong Buys and selected 7 compelling companies likely to jump sooner and climb higher than any other stock you could buy this month.You'll learn everything you need to know about these exciting trades in our brand-new Special Report, 7 Best Stocks for the Next 30 Days.Download the report free now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ventas, Inc. (VTR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Q2
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q2
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Q2 Holdings Inc
Analysen zu Q2 Holdings Inc
Datum | Rating | Analyst | |
---|---|---|---|
13.08.2019 | Q2 Buy | Compass Point | |
01.03.2019 | Q2 Buy | Needham & Company, LLC | |
19.12.2018 | Q2 Buy | BTIG Research | |
09.08.2018 | Q2 Buy | Needham & Company, LLC | |
11.05.2018 | Q2 Neutral | BTIG Research |
Datum | Rating | Analyst | |
---|---|---|---|
11.05.2018 | Q2 Neutral | BTIG Research | |
18.11.2016 | Q2 Sector Weight | Pacific Crest Securities Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Q2 Holdings Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen